All posts by Mena Q7

MenaQ7® Natto MK-7 Launched

The MenaQ7® line goes back to its roots as the Natto MK-7 variety is introduced.

 

Derived by bacillus subtilis fermentation and soy protein, MenaQ7 Natto provides all-trans isomers of K2 in a 96% active Mk-7.

 

According to NattoPharma, exclusive global supplier of MenaQ7, the only clinically validated and patented Vitamin K2 as MK-7, the company was founded on soy-based material, yet continued to innovate its offering based on market demand; namely, there was a growing concern over soy as an allergen. “But now, as a global supplier, NattoPharma has received overwhelming interest from companies looking to offer a soy Vitamin K2 as MK-7. Our response is a new variety on par with the same soy material we introduced to the market in 2004,” says Hogne Vik, chief medical officer of NattoPharma.

 

With the MenaQ7 line, NattoPharma has pioneered the manufacturing and purification standards to ensure the material delivers the active molecule, void of impurities, and validated by experts so consumers using products containing MenaQ7 are receiving the desired effect. The new Natto-derived material is a further extension of that expertise and commitment to delivering quality products that meet marketing needs.

 

MenaQ7 Natto is the result of Bacillus subtilis fermentation with a soy protein substrate providing Mk-7 and a small amount of Mk-6.  Importantly, fermentation provides only active trans isomers of the menaquinones, the active form of K2.  Other products contain inactive CIS isomers, which can be considered contaminants.

This new variety joins the industry leading MenaQ7® Crystals, NattoPharma’s natural material derived from fermented chickpeas, and the award-winning nature-identical synthetic MenaQ7® PharmaPURE.

 

MenaQ7_NattoMK-7_logo-1

 

“Climb to the Peak of Health” Message in Times Square

As a complement to its award-winning Beginner’s DHA for Kids featuring MenaQ7® Vitamin K2, Wiley’s Finest Fish Oil introduced its Adult formula at Expo West 2017. And the company’s catchy campaign – “Climb the Peak of Health” – has been a huge success, landing on Times Square (NY, NY).

 

“Playing off the fact that Vitamin K2 is both a key nutrient in this formula and the name of the second highest mountain on earth, we decided to launch this product with the campaign theme of ‘Climb the Peak of Health’. We felt it would be a fun and inspirational way to engage our valued customers and encourage them to rise to the heights of good health,” explains Wiley’s Finest™ CEO Sam Wiley.

 

The new product combines both 500mg of concentrated EPA and DHA Omega-3 from Alaska Pollock Fish Oil with a meaningful dosage of MenaQ7® K2 per serving (80mcg). Wiley’s opted for this dose after reviewing studies that showed MenaQ7® K2 delivered positive health benefits at just 45mcg per day.

 

To learn more about the product, click here.

 

Wileys Times Square

MenaQ7® Vitamin K2 Makes First For Women

The importance of Vitamin K2 reached a new level of consumer awareness when it was mentioned specifically by Dr. Dennis Goodman, cardiologist and director of integrative medicine at New York University Langone Medical Center, as an important nutrient for heart health in an article that appeared in the April 25, 2016 issue of First For Women.

 

Dr. Goodman, author of Vitamin K2: The Missing Nutrient for Heart and Bone Health, was interviewed with an esteemed panel of experts about how the appropriate form of a vitamin or supplement makes all the difference.

 

“Vitamin K2 activates substances that keep calcium in bone, where it should be,” he says, adding K1 doesn’t deliver this benefit. And if you’re also taking a calcium pill, it’s critical to take K2, he stresses. Otherwise, that calcium can build up in blood vessels to raise heart attack and stroke risk.

 

Dr. Goodman suggested First For Women readers take 45 mcg of K2 daily, “like Doctor’s Best Natural Vitamin K2 MenaQ7.”

 

To learn more, click here.

Vitamin K2 in Yogurt Effectively Increases K Status: New Study

European Journal of Clinical Nutrition published a study that adds to the growing body of evidence showing that Vitamin K2 as MenaQ7® can be delivered and is highly bioavailable through yogurt and soft gel capsules, making the nutrient safe, effective, and available to an even larger population.

 

“This important study validates obtaining Vitamin K2 from food sources is essentially equivalent to Vitamin K2 delivered in supplements,” says Hogne Vik, chief medical officer with NattoPharma, exclusive global supplier of MenaQ7. “Clearly getting Vitamin K2 from diet is ideal, be it cheese, natto, or enriched yogurts. However, as most Western populations are deficient in this essential nutrient, they are not getting enough from diet, making supplementation a viable alternative.

 

“This study further affirms that MenaQ7 is a safe and effective as either a supplement or a functional food,” adds Vik. “We see this as support for further exploring the use of MenaQ7 in yogurt and other dairy products so we can reach an even wider audience.”

 

To learn more, click here.